Pages that link to "Q34436809"
Jump to navigation
Jump to search
The following pages link to The AT2 receptor--a matter of love and hate (Q34436809):
Displaying 50 items.
- Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis (Q26749294) (← links)
- Angiotensin II in inflammation, immunity and rheumatoid arthritis (Q26991828) (← links)
- Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors (Q27023787) (← links)
- Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C. (Q27346365) (← links)
- Physiology of kidney renin (Q28279771) (← links)
- N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor Ligands (Q31160630) (← links)
- Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure (Q33389012) (← links)
- Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration (Q34248966) (← links)
- Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. (Q34423315) (← links)
- Gene expression profiles linked to AT1 angiotensin receptors in the kidney (Q34432741) (← links)
- Impact of cell type and epitope tagging on heterologous expression of G protein-coupled receptor: a systematic study on angiotensin type II receptor (Q34442688) (← links)
- Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers. (Q34543485) (← links)
- Developmental changes in AT1 and AT2 receptor-protein expression in rats (Q34557839) (← links)
- Angiotensin receptors as determinants of life span (Q35003882) (← links)
- Angiotensin type 2 receptors: blood pressure regulation and end organ damage (Q35236405) (← links)
- Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk (Q35539305) (← links)
- Angiotensin II activates AMPK for execution of apoptosis through energy-dependent and -independent mechanisms (Q35543598) (← links)
- Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands (Q35564416) (← links)
- Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra (Q35806742) (← links)
- Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease? (Q35971305) (← links)
- Angiotensin II revisited: new roles in inflammation, immunology and aging (Q36039299) (← links)
- Mechanisms of progression of chronic kidney disease (Q36120044) (← links)
- International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. (Q36241932) (← links)
- Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancer (Q36250185) (← links)
- Small-molecule AT2 receptor agonists (Q36400573) (← links)
- The Angiotensin II Type 2 Receptor in Brain Functions: An Update (Q36520049) (← links)
- Inhibition of the renin angiotensin system: implications for the endothelium (Q36552310) (← links)
- Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease (Q36576487) (← links)
- Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. (Q36663074) (← links)
- Treating patients for cardiovascular protection: combination therapy to achieve complete renin-angiotensin system blockade (Q36873154) (← links)
- Vascular angiotensin AT2 receptors in hypertension and ageing (Q37097104) (← links)
- Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis (Q37100243) (← links)
- The Frail Renin-Angiotensin System (Q37150747) (← links)
- Targeting cardiovascular protection: the concept of dual renin-angiotensin system control (Q37151935) (← links)
- RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection (Q37153633) (← links)
- Angiotensin II and oxidative stress in the failing heart (Q37166953) (← links)
- Lessons from ONTARGET. (Q37247749) (← links)
- AT2 receptors: functional relevance in cardiovascular disease. (Q37274124) (← links)
- Angiotensin type 2 receptors in the intermediolateral cell column of the spinal cord: negative regulation of sympathetic nerve activity and blood pressure. (Q37290038) (← links)
- Age-dependent differential crosstalk between alpha(1)-adrenergic and angiotensin receptors (Q37319854) (← links)
- Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus (Q37340136) (← links)
- Blocking the renin-angiotensin system: dual- versus mono-therapy (Q37511006) (← links)
- AT(2) receptor and tissue injury: therapeutic implications (Q37531017) (← links)
- The role of the central renin-angiotensin system in Parkinson's disease (Q37622568) (← links)
- Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease (Q37622578) (← links)
- The angiotensin II type 2 receptor in the brain (Q37622583) (← links)
- Novel therapeutic targets for hypertension (Q37766747) (← links)
- The renin-angiotensin system and cancer: old dog, new tricks. (Q37802186) (← links)
- Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage (Q37822830) (← links)
- Knocking Out Angiotensin II in the Heart (Q37828452) (← links)